AKT3 specifically has been shown to limit the apoptotic response through NF-κB activation [74, 88]; and by alternating AKT3 activity through mi-RNA silencing breast cancer growth is inhibited [74]. This evidence concerns the gene NFKB1 and breast carcinoma.